Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 28OTHER 24NIH 4NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 52Sarcoma 34Lymphoid 1Dermatologic 1

Conditions

Melanoma 58Lymphoma, T-Cell, Cutaneous 21Mycosis Fungoides 16Sezary Syndrome 14Lymphoma 13Lymphoma, Non-Hodgkin 12Lymphoma, Large B-Cell, Diffuse 12Lymphoma, Mantle-Cell 11Lymphoma, Large-Cell, Immunoblastic 11Lymphoma, Follicular 11Lymphoma, B-Cell, Marginal Zone 11Leukemia, Lymphocytic, Chronic, B-Cell 11Hodgkin Disease 11Burkitt Lymphoma 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, Large-Cell, Anaplastic 10Intraocular Lymphoma 9Immunoblastic Lymphadenopathy 9Breast Neoplasms 8Waldenstrom Macroglobulinemia 7Sarcoma 6Multiple Myeloma 6Leukemia, Myeloid, Chronic-Phase 6Leukemia, Myeloid, Acute 6Leukemia, Myeloid, Accelerated Phase 6Leukemia, Hairy Cell 6Carcinoma, Non-Small-Cell Lung 6Blast Crisis 6Thrombocythemia, Essential 5

Interventions

imetelstat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Glioblastoma × Dermatologic × Clear all
NCT01273090 2014-01-30

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

Children's Oncology Group

Phase 1 Completed
34 enrolled
CNSDermatologicLymphoidSarcoma

Astrocytoma, Burkitt Lymphoma, Glioblastoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoproliferative Disorders, Mycosis Fungoides, Oligodendroglioma, Recurrence, Sezary Syndrome, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Central Nervous System Neoplasms, Lymphoma, Large-Cell, Anaplastic, Neoplasms, Neuroepithelial, Optic Nerve Glioma, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡